Trenbolone Acetate
A potent 19-nor androgen originally developed for cattle, never approved for human use. Produces dramatic recomposition alongside the heaviest side-effect burden of any compound in common use.
01 Overview
Trenbolone binds the androgen receptor with very high affinity and does not aromatise, giving strong anabolic and nutrient-partitioning effects. It has no human clinical data — the profile below is drawn from veterinary pharmacology, case reports, and consistent user experience, which is why its research score is low despite how widely it is discussed.
It is not a reasonable early compound; its risk profile is categorically worse than testosterone.
02 Mechanism
High-affinity androgen-receptor agonist that does not aromatise but is progestogenic, and raises prolactin. Strong nutrient partitioning toward lean tissue is the effect users seek.
03 Dosing
| Tier | Dose | Route | Notes |
|---|---|---|---|
| Common | 150–300 mg/wk | IM | Even experienced users rarely exceed the low end; it is far stronger than the dose implies. |
| High | 300–500 mg/wk | IM | Side-effect burden rises steeply; not advisable. |
Ester comparison
| Ester | Half-life | Injection freq. | Testosterone by mass |
|---|
04 Effects
| Effect | Magnitude | Evidence | |
|---|---|---|---|
| Rapid recompositionSimultaneous lean gain and fat loss, consistently reported | Marked | Anecdotal | |
| Increased strengthReported disproportionate to the dose | Marked | Anecdotal | |
| Nutrient partitioningEstablished in livestock; not studied in humans | Strong | Preclinical |
05 Side effects
| Effect | Severity | Frequency | Evidence | Countermeasures |
|---|---|---|---|---|
| Sleep disruption and night sweatsInsomnia and heavy sweating, among the most consistently reported effects. | Moderate | Very common | Anecdotal | |
| Cardiovascular and mood effectsRaised blood pressure, adverse lipid shifts, anxiety and aggression reported more than with testosterone. | Severe | Common | Observational |
06 Commonly used with
What trenbolone is combined with, and why. This is about intent rather than safety — the interactions table below covers what is dangerous. Nothing here is listed without what it costs.
| Compound | Frequency | Purpose & trade-off |
|---|---|---|
| Stacked compounds | ||
| Testosteronebase | Testosterone base preserves libido and wellbeing that trenbolone alone strongly suppresses.Trade-off: Adds estrogenic load; some run test low to limit sides but risk sexual dysfunction from tren dominance. | |
| Testosterone propionatematched ester | Short propionate matches tren acetate's fast kinetics for a controllable cutting stack.Trade-off: Both need frequent injections, increasing injection burden and site irritation. | |
| Masterondrostanolone | Masteron adds hardness and mild anti-estrogen effect for a dry contest-prep look with tren.Trade-off: Requires low body fat to show, does little for size, and can accelerate hair loss. | |
| Support & ancillaries | ||
| Cabergolinedopamine agonist | Used to counter prolactin-related sexual dysfunction sometimes reported with the 19-nor trenbolone.Trade-off: Can cause nausea and low blood pressure, and tren sides are often not primarily prolactin-driven. | |
| Post-cycle | ||
| TamoxifenPCT | Restarts endogenous testosterone after discontinuation; the short acetate ester allows an early PCT start.Trade-off: Trenbolone suppression can be deep, so recovery may lag, and tamoxifen has mood and visual side effects. | |